{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T11:42:30Z","timestamp":1784634150680,"version":"3.55.0"},"reference-count":87,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,15]],"date-time":"2025-06-15T00:00:00Z","timestamp":1749945600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100017547","name":"Spark Therapeutics","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017547","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100032123","name":"ClearPoint Neuro","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100032123","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.ymthe.2025.06.019","type":"journal-article","created":{"date-parts":[[2025,6,14]],"date-time":"2025-06-14T02:32:49Z","timestamp":1749868369000},"page":"4239-4258","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["AAV-mediated gene therapy for focal epilepsy by expressing neuropeptide Y and Y2 receptor in rodent and non-human primate hippocampus"],"prefix":"10.1016","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-8098-6378","authenticated-orcid":false,"given":"Barbara","family":"Terzic","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7007-8434","authenticated-orcid":false,"given":"Esbj\u00f6rn","family":"Melin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pernilla","family":"Fagergren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Dobry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Cattaneo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iris","family":"Giupponi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Bettegazzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Simonato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Agerman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Merab","family":"Kokaia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence","family":"Moon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Ramsburg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2025.06.019_bib1","doi-asserted-by":"crossref","first-page":"623","DOI":"10.3390\/jpm13040623","article-title":"State of the Art and Challenges in Epilepsy\u2014A Narrative Review","volume":"13","author":"Manole","year":"2023","journal-title":"J. Pers. Med."},{"key":"10.1016\/j.ymthe.2025.06.019_bib2","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0920-1211(96)00043-5","article-title":"Introduction to temporal lobe epilepsy","volume":"26","author":"Engel","year":"1996","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.ymthe.2025.06.019_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2012\/630853","article-title":"A Review of the Epidemiology of Temporal Lobe Epilepsy","volume":"2012","author":"T\u00e9llez-Zenteno","year":"2012","journal-title":"Epilepsy Res. Treat."},{"key":"10.1016\/j.ymthe.2025.06.019_bib4","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.clineuro.2016.03.018","article-title":"Seizure outcome following medical treatment of mesial temporal lobe epilepsy: Clinical phenotypes and prognostic factors","volume":"144","author":"Kuzmanovski","year":"2016","journal-title":"Clin. Neurol. Neurosurg."},{"key":"10.1016\/j.ymthe.2025.06.019_bib5","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.yebeh.2003.10.010","article-title":"Differences in memory performance and other clinical characteristics in patients with mesial temporal lobe epilepsy with and without hippocampal atrophy","volume":"5","author":"Alessio","year":"2004","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.ymthe.2025.06.019_bib6","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.eplepsyres.2017.05.004","article-title":"Mesial temporal lobe epilepsy diminishes functional connectivity during emotion perception","volume":"134","author":"Steiger","year":"2017","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.ymthe.2025.06.019_bib7","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1111\/j.0013-9580.2004.09004.x","article-title":"Mesial Temporal Lobe Epilepsy with Hippocampal Sclerosis","volume":"45","year":"2004","journal-title":"Epilepsia"},{"key":"10.1016\/j.ymthe.2025.06.019_bib8","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/j.wneu.2016.12.074","article-title":"Prevalence and Incidence of Drug-Resistant Mesial Temporal Lobe Epilepsy in the United States","volume":"99","author":"Asadi-Pooya","year":"2017","journal-title":"World Neurosurg."},{"key":"10.1016\/j.ymthe.2025.06.019_bib9","doi-asserted-by":"crossref","first-page":"8169","DOI":"10.1523\/JNEUROSCI.17-21-08169.1997","article-title":"Inhibition of Synaptic Transmission by Neuropeptide Y in Rat Hippocampal Area CA1: Modulation of Presynaptic Ca2+ Entry","volume":"17","author":"Qian","year":"1997","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ymthe.2025.06.019_bib10","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.mcn.2008.06.014","article-title":"Activity-dependent volume transmission by transgene NPY attenuates glutamate release and LTP in the subiculum","volume":"39","author":"Sorensen","year":"2008","journal-title":"Mol. Cell Neurosci"},{"key":"10.1016\/j.ymthe.2025.06.019_bib11","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.nbd.2018.01.016","article-title":"Gene therapy mediated seizure suppression in Genetic Generalised Epilepsy: Neuropeptide Y overexpression in a rat model","volume":"113","author":"Powell","year":"2018","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.ymthe.2025.06.019_bib12","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1038\/sj.gt.3303013","article-title":"Adeno-associated virus-mediated expression and constitutive secretion of NPY or NPY13-36 suppresses seizure activity in vivo","volume":"14","author":"Foti","year":"2007","journal-title":"Gene Ther."},{"key":"10.1016\/j.ymthe.2025.06.019_bib13","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-56062-1","article-title":"Inhibition of epileptiform activity by neuropeptide Y in brain tissue from drug-resistant temporal lobe epilepsy patients","volume":"9","author":"Wickham","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ymthe.2025.06.019_bib14","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/381415a0","article-title":"Sensitivity to leptin and susceptibility to seizures of mice lacking neuropeptide Y","volume":"381","author":"Erickson","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2025.06.019_bib15","doi-asserted-by":"crossref","first-page":"8927","DOI":"10.1523\/JNEUROSCI.17-23-08927.1997","article-title":"Knock-Out Mice Reveal a Critical Antiepileptic Role for Neuropeptide Y","volume":"17","author":"Baraban","year":"1997","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ymthe.2025.06.019_bib16","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0006-8993(00)02285-X","article-title":"Behavioral characterization of neuropeptide Y knockout mice","volume":"868","author":"Bannon","year":"2000","journal-title":"Brain Res."},{"key":"10.1016\/j.ymthe.2025.06.019_bib17","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1038\/nm0797-761","article-title":"Powerful inhibition of kainic acid seizures by neuropeptide Y via Y5-like receptors","volume":"3","author":"Woldbye","year":"1997","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2025.06.019_bib18","doi-asserted-by":"crossref","first-page":"9622","DOI":"10.1523\/JNEUROSCI.3973-14.2015","article-title":"Differential Effect of Neuropeptides on Excitatory Synaptic Transmission in Human Epileptic Hippocampus","volume":"35","author":"Ledri","year":"2015","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ymthe.2025.06.019_bib19","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3389\/fendo.2013.00005","article-title":"Neuropeptide Y receptors: how to get subtype selectivity","volume":"4","author":"Pedragosa-Badia","year":"2013","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.ymthe.2025.06.019_bib20","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1002\/syn.890190303","article-title":"Neuropeptide Y and dynorphin-immunoreactive large dense-core vesicles are strategically localized for presynaptic modulation in the hippocampal formation and substantia nigra","volume":"19","author":"Pickel","year":"1995","journal-title":"Synapse"},{"key":"10.1016\/j.ymthe.2025.06.019_bib21","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1523\/JNEUROSCI.16-03-00964.1996","article-title":"Proneuropeptide Y processing in large dense-core vesicles: manipulation of prohormone convertase expression in sympathetic neurons using adenoviruses","volume":"16","author":"Paquet","year":"1996","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ymthe.2025.06.019_bib22","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1002\/cne.21046","article-title":"Characterization of neuropeptide Y2 receptor protein expression in the mouse brain. I. Distribution in cell bodies and nerve terminals","volume":"499","author":"Stani\u0107","year":"2006","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.ymthe.2025.06.019_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.npep.2017.11.003","article-title":"Peptide YY (3\u201336) modulates intracellular calcium through activation of the phosphatidylinositol pathway in hippocampal neurons","volume":"67","author":"Domingues","year":"2018","journal-title":"Neuropeptides"},{"key":"10.1016\/j.ymthe.2025.06.019_bib24","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1111\/j.1460-9568.2005.04338.x","article-title":"The anti-epileptic actions of neuropeptide Y in the hippocampus are mediated by Y2 and not Y5 receptors","volume":"22","author":"El Bahh","year":"2005","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.ymthe.2025.06.019_bib25","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1111\/j.1476-5381.1994.tb17055.x","article-title":"Neuropeptide Y inhibits potassium-stimulated glutamate release through Y2 receptors in rat hippocampal slices in vitro","volume":"113","author":"Greber","year":"1994","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ymthe.2025.06.019_bib26","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1038\/s41434-023-00399-w","article-title":"Combinatorial gene therapy for epilepsy: Gene sequence positioning and AAV serotype influence expression and inhibitory effect on seizures","volume":"30","author":"Melin","year":"2023","journal-title":"Gene Ther."},{"key":"10.1016\/j.ymthe.2025.06.019_bib27","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/0306-4522(95)00332-D","article-title":"Autoradiographic analysis of neuropeptide Y receptor binding sites in the rat hippocampus after kainic acid-induced limbic seizures","volume":"70","author":"R\u00f6Der","year":"1996","journal-title":"Neuroscience"},{"key":"10.1016\/j.ymthe.2025.06.019_bib28","doi-asserted-by":"crossref","first-page":"5804","DOI":"10.1523\/JNEUROSCI.21-15-05804.2001","article-title":"Plasticity of Y1 and Y2 Receptors and Neuropeptide Y Fibers in Patients with Temporal Lobe Epilepsy","volume":"21","author":"Furtinger","year":"2001","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ymthe.2025.06.019_bib29","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1038\/nrneurol.2014.43","article-title":"Gene therapy in epilepsy-is it time for clinical trials?","volume":"10","author":"Kullmann","year":"2014","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.ymthe.2025.06.019_bib30","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.yebeh.2013.09.013","article-title":"Gene therapy for epilepsy","volume":"38","author":"Simonato","year":"2014","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.ymthe.2025.06.019_bib31","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.yebeh.2017.12.041","article-title":"A modern epilepsy surgery treatment algorithm: Incorporating traditional and emerging technologies","volume":"80","author":"Englot","year":"2018","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.ymthe.2025.06.019_bib32","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1038\/s41573-023-00766-7","article-title":"AAV-based in vivo gene therapy for neurological disorders","volume":"22","author":"Ling","year":"2023","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ymthe.2025.06.019_bib33","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/S0140-6736(16)30371-3","article-title":"Safety and durability of effect of contralateral-eye administration of AAV2 gene therapy in patients with childhood-onset blindness caused by RPE65 mutations: a follow-on phase 1 trial","volume":"388","author":"Bennett","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.ymthe.2025.06.019_bib34","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.ymthe.2019.12.010","article-title":"AAV Vector Immunogenicity in Humans: A Long Journey to Successful Gene Transfer","volume":"28","author":"Costa Verdera","year":"2020","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2025.06.019_bib35","doi-asserted-by":"crossref","first-page":"2778","DOI":"10.1093\/brain\/awq219","article-title":"Adeno-associated viral vector-induced overexpression of neuropeptide Y Y2 receptors in the hippocampus suppresses seizures","volume":"133","author":"Woldbye","year":"2010","journal-title":"Brain"},{"key":"10.1016\/j.ymthe.2025.06.019_bib36","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.omtm.2019.09.004","article-title":"Disease Modification by Combinatorial Single Vector Gene Therapy: A Preclinical Translational Study in Epilepsy","volume":"15","author":"Melin","year":"2019","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.ymthe.2025.06.019_bib37","doi-asserted-by":"crossref","first-page":"3051","DOI":"10.1523\/JNEUROSCI.4056-03.2004","article-title":"Anticonvulsant and Antiepileptogenic Effects Mediated by Adeno-Associated Virus Vector Neuropeptide Y Expression in the Rat Hippocampus","volume":"24","author":"Richichi","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ymthe.2025.06.019_bib38","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1046\/j.1460-9568.1998.00061.x","article-title":"Anticonvulsant properties of BIBP3226, a non-peptide selective antagonist at neuropeptide Y Y1 receptors","volume":"10","author":"Gariboldi","year":"1998","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.ymthe.2025.06.019_bib39","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1046\/j.1460-9568.2003.02810.x","article-title":"Induced down-regulation of neuropeptide Y-Y1 receptors delays initiation of kindling","volume":"18","author":"Benmaamar","year":"2003","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.ymthe.2025.06.019_bib40","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1111\/j.1528-1167.2006.00500.x","article-title":"Differential Actions of NPY on Seizure Modulation via Y1 and Y2 Receptors: Evidence from Receptor Knockout Mice","volume":"47","author":"Lin","year":"2006","journal-title":"Epilepsia"},{"key":"10.1016\/j.ymthe.2025.06.019_bib41","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1056\/NEJMoa1708538","article-title":"Hemophilia B Gene Therapy with a High-Specific-Activity Factor IX Variant","volume":"377","author":"George","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymthe.2025.06.019_bib42","first-page":"647","article-title":"Imaging Neuronal Activity with Genetically Encoded Calcium Indicators","volume":"2012","author":"Tian","year":"2012","journal-title":"Cold Spring Harbor Protoc."},{"key":"10.1016\/j.ymthe.2025.06.019_bib43","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/j.neuron.2012.02.011","article-title":"Imaging Calcium in Neurons","volume":"73","author":"Grienberger","year":"2012","journal-title":"Neuron"},{"key":"10.1016\/j.ymthe.2025.06.019_bib44","doi-asserted-by":"crossref","DOI":"10.3389\/fneng.2013.00010","article-title":"Effects of antiepileptic drugs on hippocampal neurons coupled to micro-electrode arrays","volume":"6","author":"Colombi","year":"2013","journal-title":"Front. Neuroeng."},{"key":"10.1016\/j.ymthe.2025.06.019_bib45","article-title":"Revealing neuronal function through microelectrode array recordings","volume":"8","author":"Obien","year":"2014","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.ymthe.2025.06.019_bib46","doi-asserted-by":"crossref","first-page":"R3","DOI":"10.1016\/S0014-2999(99)00650-0","article-title":"BIIE0246: A selective and high affinity neuropeptide Y Y2 receptor antagonist","volume":"384","author":"Doods","year":"1999","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ymthe.2025.06.019_bib47","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/S0026-895X(24)12344-9","article-title":"Effects of the Anticonvulsant Retigabine on Cultured Cortical Neurons: Changes in Electroresponsive Properties and Synaptic Transmission","volume":"61","author":"Otto","year":"2002","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ymthe.2025.06.019_bib48","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1111\/j.1528-1167.2011.03364.x","article-title":"The spectrum of anticonvulsant efficacy of retigabine (ezogabine) in animal models: Implications for clinical use","volume":"53","author":"Large","year":"2012","journal-title":"Epilepsia"},{"key":"10.1016\/j.ymthe.2025.06.019_bib49","doi-asserted-by":"crossref","first-page":"3940","DOI":"10.1073\/pnas.82.11.3940","article-title":"Neuropeptide Y injected in the paraventricular hypothalamus: a powerful stimulant of feeding behavior","volume":"82","author":"Stanley","year":"1985","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2025.06.019_bib50","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1126\/science.1115524","article-title":"NPY\/AgRP Neurons Are Essential for Feeding in Adult Mice but Can Be Ablated in Neonates","volume":"310","author":"Luquet","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.ymthe.2025.06.019_bib51","first-page":"1411","article-title":"Regulation of feeding related behaviours by Arcuate neuropeptide Y neurons","volume":"160","author":"Zhang","year":"2019","journal-title":"Endocrinology"},{"key":"10.1016\/j.ymthe.2025.06.019_bib52","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/0006-8993(85)91223-5","article-title":"Kindling with rapidly recurring hippocampal seizures","volume":"360","author":"Lothman","year":"1985","journal-title":"Brain Res."},{"key":"10.1016\/j.ymthe.2025.06.019_bib53","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/0920-1211(93)90045-9","article-title":"Rapid kindling with recurrent hippocampal seizures","volume":"14","author":"Lothman","year":"1993","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.ymthe.2025.06.019_bib54","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.eplepsyres.2012.07.012","article-title":"Temporal evolution of neurophysiological and behavioral features of synapsin I\/II\/III triple knock-out mice","volume":"103","author":"Cambiaghi","year":"2013","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.ymthe.2025.06.019_bib55","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.neuroimage.2016.03.018","article-title":"The average baboon brain: MRI templates and tissue probability maps from 89 individuals","volume":"132","author":"Love","year":"2016","journal-title":"NeuroImage"},{"key":"10.1016\/j.ymthe.2025.06.019_bib56","first-page":"343","article-title":"Volumetric comparison of hippocampal regions in 44 primate species","volume":"35","author":"Frahm","year":"1994","journal-title":"J. Hirnforsch."},{"key":"10.1016\/j.ymthe.2025.06.019_bib57","first-page":"171","article-title":"Models and detection of spontaneous recurrent seizures in laboratory rodents","volume":"38","author":"Gu","year":"2017","journal-title":"Zool. Res."},{"key":"10.1016\/j.ymthe.2025.06.019_bib58","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.eplepsyres.2018.07.008","article-title":"In vitro and in vivo experimental models employed in the discovery and development of antiepileptic drugs for pharmacoresistant epilepsy","volume":"146","author":"Campos","year":"2018","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.ymthe.2025.06.019_bib59","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/0306-4522(83)90113-6","article-title":"Kainic acid induced seizures: Neurochemical and histopathological changes","volume":"10","author":"Sperk","year":"1983","journal-title":"Neuroscience"},{"key":"10.1016\/j.ymthe.2025.06.019_bib60","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1080\/01926230701748305","article-title":"Mesial Temporal Lobe Epilepsy: Pathogenesis, Induced Rodent Models and Lesions","volume":"35","author":"Sharma","year":"2007","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.ymthe.2025.06.019_bib61","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtm.2024.101342","article-title":"A novel AAV9-dual microRNA-vector targeting GRIK2 in the hippocampus as a treatment for mesial temporal lobe epilepsy","volume":"32","author":"Baudouin","year":"2024","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.ymthe.2025.06.019_bib62","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1002\/ana.26723","article-title":"GluK2 Is a Target for Gene Therapy in Drug-Resistant Temporal Lobe Epilepsy","volume":"94","author":"Boileau","year":"2023","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.ymthe.2025.06.019_bib63","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.brainres.2007.11.015","article-title":"Specific AAV serotypes stably transduce primary hippocampal and cortical cultures with high efficiency and low toxicity","volume":"1190","author":"Royo","year":"2008","journal-title":"Brain Res."},{"key":"10.1016\/j.ymthe.2025.06.019_bib64","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-017-02009-x","article-title":"A very large-scale microelectrode array for cellular-resolution electrophysiology","volume":"8","author":"Tsai","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2025.06.019_bib65","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1152\/jn.1997.78.3.1651","article-title":"Neuropeptide Y Suppresses Epileptiform Activity in Rat Hippocampus In Vitro","volume":"78","author":"Klapstein","year":"1997","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.ymthe.2025.06.019_bib66","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1038\/sj.bjp.0704751","article-title":"Blockade of neuropeptide Y2 receptors and suppression of NPY's anti-epileptic actions in the rat hippocampal slice by BIIE0246","volume":"136","author":"El Bahh","year":"2002","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ymthe.2025.06.019_bib67","article-title":"NPY and Gene Therapy for Epilepsy: How, When","volume":"13","author":"Cattaneo","year":"2020","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.ymthe.2025.06.019_bib68","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1002\/hipo.20740","article-title":"Tuning afferent synapses of hippocampal interneurons by neuropeptide Y","volume":"21","author":"Ledri","year":"2011","journal-title":"Hippocampus"},{"key":"10.1016\/j.ymthe.2025.06.019_bib69","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1007\/s12264-014-1478-4","article-title":"Dysfunction of hippocampal interneurons in epilepsy","volume":"30","author":"Liu","year":"2014","journal-title":"Neurosci. Bull."},{"key":"10.1016\/j.ymthe.2025.06.019_bib70","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0014-2999(02)01371-7","article-title":"Autoinhibitory function of the sympathetic prejunctional neuropeptide Y Y2 receptor evidenced by BIIE0246","volume":"439","author":"Malmstr\u00f6m","year":"2002","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ymthe.2025.06.019_bib71","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/head.13084","article-title":"Overview of Neuropeptides: Awakening the Senses?","volume":"57","author":"Russo","year":"2017","journal-title":"Headache"},{"key":"10.1016\/j.ymthe.2025.06.019_bib72","doi-asserted-by":"crossref","first-page":"4387","DOI":"10.1038\/s44319-024-00244-0","article-title":"Gene therapy for epilepsy targeting neuropeptide Y and its Y2 receptor to dentate gyrus granule cells","volume":"25","author":"Cattaneo","year":"2024","journal-title":"EMBO Rep."},{"key":"10.1016\/j.ymthe.2025.06.019_bib73","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1523\/JNEUROSCI.4379-08.2009","article-title":"Role of Dorsomedial Hypothalamic Neuropeptide Y in Modulating Food Intake and Energy Balance","volume":"29","author":"Yang","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ymthe.2025.06.019_bib74","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1038\/oby.2008.670","article-title":"Sustained NPY Overexpression in the PVN Results in Obesity via Temporarily Increasing Food Intake","volume":"17","author":"Tiesjema","year":"2009","journal-title":"Obesity"},{"key":"10.1016\/j.ymthe.2025.06.019_bib75","doi-asserted-by":"crossref","first-page":"232","DOI":"10.3389\/fnmol.2020.603409","article-title":"Gene therapy vector encoding neuropeptide Y and its receptor Y2 for future treatment of epilepsy: preclinical data in rats","volume":"13","author":"Szczygie\u0142","year":"2020","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.ymthe.2025.06.019_bib76","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1006\/mthe.2002.0673","article-title":"Intramuscular Administration of Recombinant Adeno-Associated Virus 2 \u03b1-1 Antitrypsin (rAAV-SERPINA1) Vectors in a Nonhuman Primate Model: Safety and Immunologic Aspects","volume":"6","author":"Song","year":"2002","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2025.06.019_bib77","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1038\/sj.gt.3303020","article-title":"Myocarditis following adeno-associated viral gene expression of human soluble TNF receptor (TNFRII-Fc) in baboon hearts","volume":"14","author":"McTiernan","year":"2007","journal-title":"Gene Ther."},{"key":"10.1016\/j.ymthe.2025.06.019_bib78","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/jgm.990","article-title":"Specific adeno-associated virus serotypes facilitate efficient gene transfer into human and non-human primate mesenchymal stromal cells","volume":"9","author":"Chng","year":"2007","journal-title":"J. Gene Med."},{"key":"10.1016\/j.ymthe.2025.06.019_bib79","doi-asserted-by":"crossref","first-page":"E4812","DOI":"10.1073\/pnas.1704766114","article-title":"Structure-guided evolution of antigenically distinct adeno-associated virus variants for immune evasion","volume":"114","author":"Tse","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2025.06.019_bib80","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1111\/j.1600-0684.1993.tb00694.x","article-title":"Cross-sectional growth standards for captive baboons: II. Organ weight by body weight","volume":"22","author":"Mahaney","year":"1993","journal-title":"J. Med. Primatol."},{"key":"10.1016\/j.ymthe.2025.06.019_bib81","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1159\/000488136","article-title":"Primate brain anatomy: new volumetric MRI measurements for neuroanatomical studies","volume":"91","author":"Navarrete","year":"2018","journal-title":"Brain Behav. Evol."},{"key":"10.1016\/j.ymthe.2025.06.019_bib82","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1089\/hum.2011.031","article-title":"Impact of Pre-Existing Immunity on Gene Transfer to Nonhuman Primate Liver with Adeno-Associated Virus 8 Vectors","volume":"22","author":"Wang","year":"2011","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymthe.2025.06.019_bib83","doi-asserted-by":"crossref","first-page":"3159","DOI":"10.1523\/JNEUROSCI.1143-18.2019","article-title":"Epilepsy Gene Therapy Using an Engineered Potassium Channel","volume":"39","author":"Snowball","year":"2019","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ymthe.2025.06.019_bib84","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.201809963","article-title":"Dynorphin-based \"release on demand\" gene therapy for drug-resistant temporal lobe epilepsy","volume":"11","author":"Agostinho","year":"2019","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.ymthe.2025.06.019_bib85","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0920-1211(99)00052-2","article-title":"Molecular neuropathology of human mesial temporal lobe epilepsy","volume":"36","author":"Bl\u00fcmcke","year":"1999","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.ymthe.2025.06.019_bib86","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0306-4522(02)00064-7","article-title":"Evolution of hippocampal epileptic activity during the development of hippocampal sclerosis in a mouse model of temporal lobe epilepsy","volume":"112","author":"Riban","year":"2002","journal-title":"Neuroscience"},{"key":"10.1016\/j.ymthe.2025.06.019_bib87","doi-asserted-by":"crossref","first-page":"11368","DOI":"10.1523\/JNEUROSCI.3795-04.2004","article-title":"Different Presynaptic Roles of Synapsins at Excitatory and Inhibitory Synapses","volume":"24","author":"Gitler","year":"2004","journal-title":"J. Neurosci."}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001625004708?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001625004708?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T20:26:33Z","timestamp":1782505593000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001625004708"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":87,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S1525001625004708"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2025.06.019","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"AAV-mediated gene therapy for focal epilepsy by expressing neuropeptide Y and Y2 receptor in rodent and non-human primate hippocampus","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2025.06.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}]}}